Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HMD4
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 1 |
GO:0009266 | response to temperature stimulus | 3 | 1 |
GO:0009408 | response to heat | 3 | 1 |
GO:0009628 | response to abiotic stimulus | 2 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0003729 | mRNA binding | 5 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043169 | cation binding | 3 | 9 |
GO:0046872 | metal ion binding | 4 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 100 | 102 | PF00675 | 0.550 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.617 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 21 | 23 | PF00082 | 0.602 |
CLV_PCSK_PC1ET2_1 | 99 | 101 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.668 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.325 |
DOC_CDC14_PxL_1 | 230 | 238 | PF14671 | 0.613 |
DOC_CKS1_1 | 162 | 167 | PF01111 | 0.584 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.701 |
DOC_USP7_MATH_1 | 257 | 261 | PF00917 | 0.660 |
DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.574 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.579 |
LIG_14-3-3_CanoR_1 | 124 | 132 | PF00244 | 0.557 |
LIG_14-3-3_CanoR_1 | 149 | 154 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 285 | 292 | PF00244 | 0.648 |
LIG_14-3-3_CanoR_1 | 72 | 78 | PF00244 | 0.524 |
LIG_Actin_WH2_2 | 56 | 74 | PF00022 | 0.325 |
LIG_APCC_ABBA_1 | 197 | 202 | PF00400 | 0.605 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.527 |
LIG_DLG_GKlike_1 | 149 | 156 | PF00625 | 0.477 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.583 |
LIG_FHA_2 | 104 | 110 | PF00498 | 0.444 |
LIG_FHA_2 | 285 | 291 | PF00498 | 0.649 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.516 |
LIG_FHA_2 | 81 | 87 | PF00498 | 0.518 |
LIG_IBAR_NPY_1 | 183 | 185 | PF08397 | 0.508 |
LIG_LIR_Apic_2 | 219 | 224 | PF02991 | 0.642 |
LIG_LIR_Nem_3 | 238 | 244 | PF02991 | 0.655 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.636 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.415 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.630 |
LIG_SH3_3 | 212 | 218 | PF00018 | 0.597 |
LIG_SH3_3 | 228 | 234 | PF00018 | 0.625 |
LIG_SH3_3 | 239 | 245 | PF00018 | 0.652 |
LIG_SH3_3 | 298 | 304 | PF00018 | 0.650 |
LIG_TRAF2_1 | 263 | 266 | PF00917 | 0.646 |
LIG_TRAF2_1 | 83 | 86 | PF00917 | 0.463 |
LIG_TRFH_1 | 187 | 191 | PF08558 | 0.593 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.514 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.645 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.506 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.561 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.719 |
MOD_CK1_1 | 260 | 266 | PF00069 | 0.753 |
MOD_CK1_1 | 272 | 278 | PF00069 | 0.437 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.430 |
MOD_CK2_1 | 260 | 266 | PF00069 | 0.764 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.606 |
MOD_CK2_1 | 80 | 86 | PF00069 | 0.490 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.438 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.654 |
MOD_GlcNHglycan | 273 | 277 | PF01048 | 0.644 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.493 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.627 |
MOD_LATS_1 | 147 | 153 | PF00433 | 0.472 |
MOD_N-GLC_1 | 260 | 265 | PF02516 | 0.556 |
MOD_NEK2_1 | 279 | 284 | PF00069 | 0.478 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.604 |
MOD_PIKK_1 | 174 | 180 | PF00454 | 0.507 |
MOD_PIKK_1 | 235 | 241 | PF00454 | 0.699 |
MOD_PIKK_1 | 244 | 250 | PF00454 | 0.622 |
MOD_PKA_2 | 284 | 290 | PF00069 | 0.596 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.516 |
MOD_Plk_2-3 | 135 | 141 | PF00069 | 0.505 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.627 |
MOD_Plk_4 | 232 | 238 | PF00069 | 0.641 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.500 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.581 |
MOD_SUMO_for_1 | 52 | 55 | PF00179 | 0.356 |
MOD_SUMO_rev_2 | 29 | 37 | PF00179 | 0.598 |
TRG_DiLeu_BaEn_3 | 32 | 38 | PF01217 | 0.553 |
TRG_DiLeu_BaEn_4 | 33 | 39 | PF01217 | 0.535 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.629 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.636 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2D6 | Leptomonas seymouri | 48% | 100% |
A0A1X0NIQ2 | Trypanosomatidae | 33% | 100% |
A0A3Q8IG28 | Leishmania donovani | 77% | 97% |
A4IB01 | Leishmania infantum | 77% | 97% |
C9ZNK2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 84% |
E9AES9 | Leishmania major | 74% | 100% |
E9B5Y4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 98% |